Maria Virgilio

Ms. Maria Virgilio

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2012 in Blood
Verified
Journal Article
Open access
PDF file
EPElspeth M. Payne
Elspeth M. Payne
MVMaria Virgilio
Maria Virgilio
ANAnupama Narla
Anupama Narla
HSHong Sun
Hong Sun
MLMichelle Levine
Michelle Levine
AKArati Khanna-Gupta
Arati Khanna-Gupta
Haploinsufficiency of ribosomal proteins (RPs) has been proposed to be the common basis for the anemia observed in Diamond-Blackfan anemia (DBA) and myelodysplastic syndrome with loss of chromosome 5q [del(5q) MDS]. We have modeled DBA and del(5q) MDS in zebrafish using antisense morpholinos to rps19 and rps14, respectively, and have demonstrated that, as in humans, haploinsufficient levels of these proteins lead to a profound anemia. To address the hypothesis that RP loss results in impaired mRNA translation, we treated Rps19 and Rps14-deficient embryos with the amino acid L-leucine, a known activator of mRNA translation. This resulted in a striking improvement of the anemia associated with RP loss. We confirmed our findings in primary human CD34+ cells, after shRNA knockdown of RPS19 and RPS14. Furthermore, we showed that loss of Rps19 or Rps14 activates the mTOR pathway, and this is accentuated by L-leucine in both Rps19 and Rps14 morphants. This effect could be abrogated by rapamycin suggesting that mTOR signaling may be responsible for the improvement in anemia associated with L-leucine. Our studies support the rationale for ongoing clinical trials of L-leucine as a therapeutic agent for DBA, and potentially for patients with del(5q) MDS.

13 October 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
CLChen Li
Chen Li
MVMaria Virgilio
Maria Virgilio
KCKathleen L. Collins
Kathleen L. Collins
JWJoshua D. Welch
Joshua D. Welch

24 April 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YLYun Li
Yun Li
JMJulien Muffat
Julien Muffat
AJAttya Omer Javed
Attya Omer Javed
HKHeather R. Keys
Heather R. Keys
TLTenzin Lungjangwa
Tenzin Lungjangwa
RJRudolf Jaenisch
Rudolf Jaenisch
Significance: Zika virus (ZIKV) is a neurotropic and neurovirulent arbovirus that has severe detrimental impact on the developing human fetal brain. We used a genome-wide CRISPR-Cas9 knockout screen to identify ZIKV host genes in human neural progenitors. The screen identified host factors involved in heparan sulfation, endocytosis, endoplasmic reticulum processing, Golgi function, and interferon activity. Our findings provide insights into host-dependent mechanisms for ZIKV infection in the highly vulnerable human neural progenitor cells and identify molecular targets for potential therapeutic intervention.

1 December 2018 in Cell Reports
Verified
Journal Article
Open access
TZThomas D. Zaikos
Thomas D. Zaikos
VTValeri H. Terry
Valeri H. Terry
NKNadia T. Sebastian Kettinger
Nadia T. Sebastian Kettinger
JLJay Lubow
Jay Lubow
MPMark M. Painter
Mark M. Painter
KCKathleen Collins
Kathleen Collins
Long-lived reservoirs of persistent HIV are a major barrier to a cure. CD4+ hematopoietic stem and progenitor cells (HSPCs) have the capacity for lifelong survival, self-renewal, and the generation of daughter cells. Recent evidence shows that they are also susceptible to HIV infection in vitro and in vivo. Whether HSPCs harbor infectious virus or contribute to plasma virus (PV) is unknown. Here, we provide strong evidence that clusters of identical proviruses from HSPCs and their likely progeny often match residual PV. A higher proportion of these sequences match residual PV than proviral genomes from bone marrow and peripheral blood mononuclear cells that are observed only once. Furthermore, an analysis of near-full-length genomes isolated from HSPCs provides evidence that HSPCs harbor functional HIV proviral genomes that often match residual PV. These results support the conclusion that HIV-infected HSPCs form a distinct and functionally significant reservoir of persistent HIV in infected people.

2 March 2020 in eLife
Verified
Journal Article
Open access
JLJay Lubow
Jay Lubow
MVMaria Virgilio
Maria Virgilio
MMMadeline Merlino
Madeline Merlino
DCDavid R Collins
David R Collins
MMMichael Mashiba
Michael Mashiba
KCKathleen Collins
Kathleen Collins
HIV-1 Vpr is necessary for maximal HIV infection and spread in macrophages. Evolutionary conservation of Vpr suggests an important yet poorly understood role for macrophages in HIV pathogenesis. Vpr counteracts a previously unknown macrophage-specific restriction factor that targets and reduces the expression of HIV Env. Here, we report that the macrophage mannose receptor (MR), is a restriction factor targeting Env in primary human monocyte-derived macrophages. Vpr acts synergistically with HIV Nef to target distinct stages of the MR biosynthetic pathway and dramatically reduce MR expression. Silencing MR or deleting mannose residues on Env rescues Env expression in HIV-1-infected macrophages lacking Vpr. However, we also show that disrupting interactions between Env and MR reduces initial infection of macrophages by cell-free virus. Together these results reveal a Vpr-Nef-Env axis that hijacks a host mannose-MR response system to facilitate infection while evading MR’s normal role, which is to trap and destroy mannose-expressing pathogens.

21 January 2020 in Viruses
Verified
Journal Article
Open access
PDF file
MVMaria Virgilio
Maria Virgilio
KCKathleen Collins
Kathleen Collins
Human immunodeficiency virus (HIV) is a chronic infection that destroys the immune system in infected individuals. Although antiretroviral therapy is effective at preventing infection of new cells, it is not curative. The inability to clear infection is due to the presence of a rare, but long-lasting latent cellular reservoir. These cells harboring silent integrated proviral genomes have the potential to become activated at any moment, making therapy necessary for life. Latently-infected cells can also proliferate and expand the viral reservoir through several methods including homeostatic proliferation and differentiation. The chromosomal location of HIV proviruses within cells influences the survival and proliferative potential of host cells. Proliferating, latently-infected cells can harbor proviruses that are both replication-competent and defective. Replication-competent proviral genomes contribute to viral rebound in an infected individual. The majority of available techniques can only assess the integration site or the proviral genome, but not both, preventing reliable evaluation of HIV reservoirs.